DS9

(2R)-14-fluoro-2-methyl-6,9,10,19-tetrazapentacyclo[14.2.1.02,6.08,18.012,17]nonadeca-1(18),8,12(17),13,15-pentaen-11-one

Created:2019-08-23
Last modified:  2020-12-16

Find related ligands:

Chemical Details

Formal Charge0
Atom Count37
Chiral Atom Count1
Bond Count41
Aromatic Bond Count10
2D diagram of DS9

Chemical Component Summary

Name(2R)-14-fluoro-2-methyl-6,9,10,19-tetrazapentacyclo[14.2.1.02,6.08,18.012,17]nonadeca-1(18),8,12(17),13,15-pentaen-11-one
FormulaC16 H15 F N4 O
Molecular Weight298.315
TypeNON-POLYMER

Chemical Descriptors

TypeProgramVersionDescriptor
SMILESCACTVS3.385C[C]12CCCN1CC3=NNC(=O)c4cc(F)cc5[nH]c2c3c45
SMILESOpenEye OEToolkits2.0.7CC12CCCN1CC3=NNC(=O)c4cc(cc5c4c3c2[nH]5)F
Canonical SMILESCACTVS3.385 C[C@]12CCCN1CC3=NNC(=O)c4cc(F)cc5[nH]c2c3c45
Canonical SMILESOpenEye OEToolkits2.0.7 C[C@]12CCCN1CC3=NNC(=O)c4cc(cc5c4c3c2[nH]5)F
InChIInChI1.03 InChI=1S/C16H15FN4O/c1-16-3-2-4-21(16)7-11-13-12-9(15(22)20-19-11)5-8(17)6-10(12)18-14(13)16/h5-6,18H,2-4,7H2,1H3,(H,20,22)/t16-/m1/s1
InChIKeyInChI1.03 DENYZIUJOTUUNY-MRXNPFEDSA-N

Drug Info: DrugBank

DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License
DrugBank IDDB14769 
NamePamiparib
Groups investigational
DescriptionPamiparib is under investigation in clinical trial NCT03933761 (Pamiparib in Fusion Positive, Reversion Negative High Grade Serous Ovarian Cancer or Carcinosarcoma With BRCA1/2 Gene Mutations If Progression on Substrate Poly ADP Ribose Polymerase Inhibitbor (PARPI) or Chemotherapy).
SynonymsPamiparib
Categories
  • Antineoplastic Agents
  • Antineoplastic and Immunomodulating Agents
  • Enzyme Inhibitors
  • Poly (ADP-ribose) polymerase (PARP) inhibitors
  • Poly(ADP-ribose) Polymerase Inhibitors
ATC-CodeL01XK06
CAS number1446261-44-4

Related Resource References

Resource NameReference
Pharos CHEMBL4112930
PubChem 135565554
ChEMBL CHEMBL4112930